Management of Pleural Effusion After Open Heart Surgery
Intervene with ultrasound-guided thoracentesis only when the effusion is symptomatic (dyspnea, increased respiratory support, cough, tachypnea, or pleuritic pain) AND either occupies >25–33% of the hemithorax or exceeds 400–480 mL in volume; asymptomatic effusions should be observed regardless of size. 1
Understanding Post-Cardiac Surgery Effusions
Prevalence and Natural History
- Pleural effusions develop radiographically in 42–89% of patients after cardiac surgery, but only 6.6% require therapeutic intervention 2
- The vast majority follow a benign, self-limited course without affecting mortality 2
- Approximately 21% of drained effusions recur despite initial intervention 2
Temporal Classification and Fluid Characteristics
Early effusions (≤30 days post-surgery):
- Characteristically exudative with elevated erythrocyte counts, elevated LDH, and eosinophilia 2, 3
- Reflect direct surgical trauma, bleeding, and pleural inflammation 2, 3
Late effusions (>30 days post-surgery):
- Predominantly lymphocytic with lower LDH levels 2
- Suggest an immune-mediated process rather than surgical trauma 2
Clinical Assessment Algorithm
Step 1: Determine Clinical Significance
The effusion is clinically significant if ANY of the following are present:
- Increased need for respiratory support 2
- Dyspnea or shortness of breath 2
- Cough or tachypnea 2
- Pleuritic chest pain 2
If asymptomatic: Observe regardless of effusion size—no intervention needed 2, 1
Step 2: Radiographic Sizing
- Use chest radiography to classify as small (<25% hemithorax), moderate, or large (>25–33% hemithorax) 2
- Ultrasound provides superior sensitivity for detecting fluid and identifying features suggesting complication (loculations, septations, echogenic debris) 1, 4
Step 3: Apply Intervention Thresholds
Drain the effusion when BOTH criteria are met:
- Patient is symptomatic (see Step 1) AND
- Volume exceeds 480 mL (reduces hospital stay by 3±1.5 days vs. diuretics alone) 2 OR
- Volume exceeds 400 mL OR any volume with symptoms (improves walking distance and recovery by up to 15%) 2
Drainage Technique and Safety
Preferred Method
- Ultrasound-guided thoracentesis is first-line, replacing surgical tube thoracostomy 2, 1
- Ultrasound guidance reduces pneumothorax risk (blind thoracentesis carries ~19% pneumothorax risk) 1
Volume Limits
- Remove 1–1.5 L maximum per session to prevent re-expansion pulmonary edema 1
Fluid Analysis
Routine studies on all diagnostic thoracenteses:
Additional testing when indicated:
- Triglycerides if chylothorax suspected (milky appearance, thoracic duct injury) 2, 5
- Tuberculosis testing in high-prevalence regions 4
Specific Complications Requiring Urgent Drainage
Infected Effusion (Empyema)
Drain immediately if ANY of the following:
Hemodynamic Compromise
- Hemodynamic instability or tamponade physiology warrants immediate diagnostic and therapeutic thoracentesis 1
Adjunctive Medical Management
Post-Pericardiotomy Syndrome
- First-line: NSAIDs for symptomatic relief 2
- Preventive therapy: Colchicine postoperatively reduces syndrome incidence 2, 6
Fluid Management Optimization
- Use buffered crystalloids (Ringer's lactate or acetate) instead of 0.9% saline 1, 6
- Target conservative positive fluid balance of 1–2 L by end of operative case; reduce further when effusion present 1, 6
- Avoid albumin and synthetic colloids—these increase bleeding, re-sternotomy, and infection risk without improving outcomes 6
Critical Pitfalls to Avoid
- Never drain asymptomatic effusions—this exposes patients to procedural risk (pneumothorax, bleeding, infection) without clinical benefit 1
- Never perform blind thoracentesis—always use ultrasound guidance 1
- Do not rely on exudative vs. transudative distinction alone—nearly all post-cardiac surgery effusions are exudative by Light's criteria, but most are benign and self-limited 3
- Do not use hydroxyethyl starch or routine albumin—these worsen outcomes in cardiac surgery patients 6
- Do not delay drainage of infected effusions—pH <7.2 mandates prompt catheter or chest tube drainage, possibly with tissue plasminogen activator/DNase therapy 1, 4